Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01623440 · ClinicalTrials.gov registry record
Food Reward in Native American Women
A clinical trial of Obesity, sponsored by University of Minnesota.
- Completed
- Registry status
- 69
- Enrollment target
- 1
- Study location
NCT01623440 is a study of Obesity that has completed, run by University of Minnesota. The registered enrollment target is 69 participants, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (92% lower). The trial reports 1 study location across 1 state.
The verdict
NCT01623440, a study of Obesity, has completed, sponsored by University of Minnesota.
- COMPLETED
- Registry status
- 69 participants
- Enrollment target
- 1
- Study location
Study Summary
This study aims to characterize the neurobiology of obesity in American Indians (AI) using functional MRIs to examine the correlation between brain response to food stimuli in AI women. A functional MRI (fMRI) is used to visualize brain activity when obese and lean AI women look at images of fattening food, non-fattening food and non-food objects. Additionally examined is the effect of the drug naltrexone to suppress brain response to visual food cues and calorie intake in the women.
Conditions Studied
Interventions
- COMBINATION_PRODUCT Placebo and fMRI
- COMBINATION_PRODUCT Naltrexone and fMRI
Study Locations (1)
Minnesota
- University of Minnesota - Minneapolis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 69 participants |
| Start Date | 2009-11 |
| Est. Completion | 2015-07 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01623440
The ClinicalTrials.gov registry entry for NCT01623440 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 69 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (92% lower). The listed sponsor is University of Minnesota, which has 966 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Obesity appearing as the primary indexed condition, and to 2 interventions - of which Placebo and fMRI is the first listed.
NCT01623440 reports 1 study location spanning 1 distinct geographic area - top geographies include Minnesota.
Frequently Asked Questions
What is clinical trial NCT01623440 about?
NCT01623440 is a clinical study titled "Food Reward in Native American Women". This study aims to characterize the neurobiology of obesity in American Indians (AI) using functional MRIs to examine the correlation between brain response to food stimuli in AI women. A functional MRI (fMRI) is used to visualize brain activity when obese and lean AI women look at images of fatteni...
What is the current status of trial NCT01623440?
This trial is currently completed. The enrollment target is 69 participants. The study started on 2009-11. Estimated completion is 2015-07.
What conditions does trial NCT01623440 study?
This clinical trial studies the following conditions: Obesity.
What interventions are being tested in trial NCT01623440?
The interventions under investigation include: Placebo and fMRI (COMBINATION_PRODUCT), Naltrexone and fMRI (COMBINATION_PRODUCT).
Who is sponsoring clinical trial NCT01623440?
This trial is sponsored by University of Minnesota, which has 966 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01623440 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Obesity
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A Hip Flexion Feedback System for Exercise Monitoring in Individuals With Osteoarthritis and Obesity
RECRUITING · Phase 1
-
Metabolic Adaptations to Weight Loss With and Without Exercise
RECRUITING · NA
-
Testing an Integrated PTSD and Weight Management Intervention: A Hybrid Type 1 Trial
RECRUITING · NA
-
TIRzepatide for the Treatment of Obesity in Patients With Atrial Fibrillation
RECRUITING · Phase 2
-
Tirzepatide: Reversal of Lipotoxicity and Adipose Tissue Dysfunction in Humans With Overweight/Obesity
RECRUITING · Phase 2
-
Tai Chi as a Novel Strategy to Increase Physical Activity Among Adults Pursuing Metabolic and Bariatric Surgery
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.